BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 17350466)

  • 1. Novel chromosomal aberrations in a recurrent malignant meningioma.
    Pelz AF; Klawunde P; Skalej M; Wieacker P; Kirches E; Schneider T; Mawrin C
    Cancer Genet Cytogenet; 2007 Apr; 174(1):48-53. PubMed ID: 17350466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative genomic hybridization analysis of genomic alterations in benign, atypical and anaplastic meningiomas.
    Arslantas A; Artan S; Oner U; Durmaz R; Müslümanoğlu H; Atasoy MA; Başaran N; Tel E
    Acta Neurol Belg; 2002 Jun; 102(2):53-62. PubMed ID: 12161900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratumoral patterns of clonal evolution in meningiomas as defined by multicolor interphase fluorescence in situ hybridization (FISH): is there a relationship between histopathologically benign and atypical/anaplastic lesions?
    Sayagués JM; Tabernero MD; Maíllo A; Espinosa A; Rasillo A; Díaz P; Ciudad J; López A; Merino M; Gonçalves JM; Santos-Briz A; Morales F; Orfao A
    J Mol Diagn; 2004 Nov; 6(4):316-25. PubMed ID: 15507670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Array-based comparative genomic hybridization of mapped BAC DNA clones to screen for chromosome 14 copy number abnormalities in meningiomas.
    Espinosa AB; Mackintosh C; Maíllo A; Gutierrez L; Sousa P; Merino M; Ortiz J; de Alava E; Orfao A; Tabernero MD
    Eur J Hum Genet; 2008 Dec; 16(12):1450-8. PubMed ID: 18628790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of material from chromosome arm 1p during malignant progression of meningioma revealed by fluorescent in situ hybridization.
    Ishino S; Hashimoto N; Fushiki S; Date K; Mori T; Fujimoto M; Nakagawa Y; Ueda S; Abe T; Inazawa J
    Cancer; 1998 Jul; 83(2):360-6. PubMed ID: 9669820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization of permanent cell lines from primary, metastatic and recurrent malignant peripheral nerve sheath tumors (MPNST) with underlying neurofibromatosis-1.
    Fang Y; Elahi A; Denley RC; Rao PH; Brennan MF; Jhanwar SC
    Anticancer Res; 2009 Apr; 29(4):1255-62. PubMed ID: 19414372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A combination of molecular cytogenetic analyses reveals complex genetic alterations in conventional renal cell carcinoma.
    Strefford JC; Stasevich I; Lane TM; Lu YJ; Oliver T; Young BD
    Cancer Genet Cytogenet; 2005 May; 159(1):1-9. PubMed ID: 15860350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of complex chromosome aberrations in a recurrent meningioma combining standard cytogenetic and array comparative genomic hybridization techniques.
    Woo KS; Sung KS; Kim KU; Shaffer LG; Han JY
    Cancer Genet Cytogenet; 2008 Jan; 180(1):56-9. PubMed ID: 18068535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of chromosome 1p deletion using FISH on meningioma touch imprints suggest a region outside chromosome 22 as important in tumor recurrence.
    Tamiolakis D; Papadopoulos N; Lambropoulou M; Kotini A; Simopoulos C
    Minerva Med; 2003 Feb; 94(1):51-6. PubMed ID: 12719702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion of chromosome 1p and loss of expression of alkaline phosphatase indicate progression of meningiomas.
    Müller P; Henn W; Niedermayer I; Ketter R; Feiden W; Steudel WI; Zang KD; Steilen-Gimbel H
    Clin Cancer Res; 1999 Nov; 5(11):3569-77. PubMed ID: 10589773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of numerical chromosome aberrations in meningioma tumors as revealed by fluorescence in situ hybridization using 10 chromosome-specific probes.
    Sayagués JM; Tabernero MD; Maillo A; Díaz P; Rasillo A; Bortoluci A; Gomez-Moreta J; Santos-Briz A; Morales F; Orfao A
    Cytometry; 2002 Jun; 50(3):153-9. PubMed ID: 12116338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of cytogenetics and FISH in the diagnosis of meningiomas. A study of 189 tumors.
    Zattara-Cannoni H; Gambarelli D; Dufour H; Figarella D; Vollot F; Grisoli F; Vagner-Capodano AM
    Ann Genet; 1998; 41(3):164-75. PubMed ID: 9833072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cytogenetic aberrations in histologically benign infiltratively growing sphenoid wing meningiomas].
    Korshunov AG; Cherekaev VA; Bekiashev AKh; Sycheva RV
    Zh Vopr Neirokhir Im N N Burdenko; 2007; (4):11-5. PubMed ID: 18274131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cytogenetic relationship between primary and recurrent meningiomas points to the need for new treatment strategies in cases at high risk of relapse.
    Espinosa AB; Tabernero MD; Maíllo A; Sayagués JM; Ciudad J; Merino M; Alguero MC; Lubombo AM; Sousa P; Santos-Briz A; Orfao A
    Clin Cancer Res; 2006 Feb; 12(3 Pt 1):772-80. PubMed ID: 16467088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic alterations in lung adenocarcinomas detected by multicolor fluorescence in situ hybridization and comparative genomic hybridization.
    Shen H; Zhu Y; Wu YJ; Qiu HR; Shu YQ
    Cancer Genet Cytogenet; 2008 Mar; 181(2):100-7. PubMed ID: 18295661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic changes with prognostic value in histologically benign meningiomas.
    Barbera S; San Miguel T; Gil-Benso R; Muñoz-Hidalgo L; Roldan P; Gonzalez-Darder J; Cerda-Nicolas M; Lopez-Gines C
    Clin Neuropathol; 2013; 32(4):311-7. PubMed ID: 23442303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of chromosome 14 abnormalities by interphase in situ hybridization and comparative genomic hybridization in 124 meningiomas: correlation with clinical, histopathologic, and prognostic features.
    Tabernero MD; Espinosa AB; Maíllo A; Sayagués JM; Alguero Mdel C; Lumbreras E; Díaz P; Gonçalves JM; Onzain I; Merino M; Morales F; Orfao A
    Am J Clin Pathol; 2005 May; 123(5):744-51. PubMed ID: 15981814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic aggressiveness in benign meningiomas with chromosomal instabilities.
    Monleón D; Morales JM; Gonzalez-Segura A; Gonzalez-Darder JM; Gil-Benso R; Cerdá-Nicolás M; López-Ginés C
    Cancer Res; 2010 Nov; 70(21):8426-34. PubMed ID: 20861191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High resolution genomic profiling and classical cytogenetics in a group of benign and atypical meningiomas.
    Holland H; Mocker K; Ahnert P; Kirsten H; Hantmann H; Koschny R; Bauer M; Schober R; Scholz M; Meixensberger J; Krupp W
    Cancer Genet; 2011 Oct; 204(10):541-9. PubMed ID: 22137484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant progression in meningioma: documentation of a series and analysis of cytogenetic findings.
    Al-Mefty O; Kadri PA; Pravdenkova S; Sawyer JR; Stangeby C; Husain M
    J Neurosurg; 2004 Aug; 101(2):210-8. PubMed ID: 15309910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.